Professor, Neurology, Mayo Medical School
Neurology
Dr. Dean M. Wingerchuk, MD
|
|
Give Review
Dean Wingerchuk is an expert in the field of Neurology. He attended University of Saskatchewan College of Medicine. He over the years received 1 awards: "Super Doctor". Dean Wingerchuk is also published. He has 98 publications published. The lastest publication: "Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonography.' Dean Wingerchuk accepts Medicare payments and is registered with Medicare.gov.
Publications
- Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap Syndromes.
- Physical activity level and future risk of mild cognitive impairment or dementia: a critically appraised topic.
- Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
- Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
- Active and progressive: A new duality of MS classification.
- Aquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis.
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis Optica spectrum disorders: an open-label pilot study.
- "Response to the commentary on "neuromyelitis Optica: potential roles for intravenous immunoglobulin".
- The effect of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures: a critically appraised topic.
- Neuromyelitis Optica: potential roles for intravenous immunoglobulin.
- Effects of Age and Sex on Aquaporin-4 Autoimmunity.
- Is Donepezil Effective for Multiple Sclerosis-related Cognitive Dysfunction?: A Critically Appraised Topic.
- The emerging relationship between neuromyelitis optica and Systemic rheumatologic autoimmune disease.
- Safety and Efficacy of Ultrasound-enhanced Thrombolysis in the Treatment of Acute Middle Cerebral Artery Infarction: A Critically Appraised Topic.
- White matter disease: Optimizing rituximab therapy for neuromyelitis Optica.
- Risk of Development of Medication Overuse Headache With Nonsteroidal Anti-inflammatory Drug Therapy for Migraine: A Critically Appraised Topic.
- IFN{beta}-1b may severely exacerbate Japanese Opticspinal MS in neuromyelitis Optica spectrum: Japanese Optic-spinal MS: Is it MS or neuromyelitis Optica and does the ...
- What is the Effect of Low-molecular Weight Heparin for Venous Thromboembolism Prophylaxis Compared With Mechanical Methods, on the Occurrence of Hemorrhagic and Venous...
- Timing of antiepileptic drug withdrawal in adult Epilepsy patients after neocortical surgical resection: a critically appraised topic.
- Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
- Environmental factors in Multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
- Surgical decompression improves mortality and morbidity after large territory acute Cerebral infarction: a critically appraised topic.
- Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic.
- Japanese Optic-spinal MS: is it MS or neuromyelitis Optica and does the answer dictate treatment?
- Do antiepileptic drugs increase the risk of suicidality in adult patients with Epilepsy?: a critically appraised topic.
- Clinical practice. Transverse myelitis.
- Supplementing our understanding of vitamin D and Multiple sclerosis.
- Are corticosteroids efficacious for preventing or treating neutralizing antibodies in Multiple sclerosis patients treated with beta-interferons? A critically appraised...
- Are corticosteroid and antiviral treatments effective for bell Palsy? A critically appraised topic.
- Skin biopsy for diagnosis of small fiber Neuropathy: a critically appraised topic.
- Do cannabinoids reduce Multiple sclerosis-related spasticity?
- The role of corticosteroids in the management of chronic subdural hematomas: a critically appraised topic.
- Treatment of neuromyelitis Optica with mycophenolate mofetil: retrospective analysis of 24 patients.
- Diagnosis of neuromyelitis spectrum Disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays.
- Efficacy of rivastigmine for cognitive symptoms in Parkinson Disease with dementia.
- Telemedicine versus telephone for remote emergency Stroke consultations: a critically appraised topic.
- Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central Nervous system sarcoidosis.
- Coexistence of Myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
- Atraumatic lumbar puncture needles: after all these years, are we still missing the point?
- Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topic.
- Treatment of neuromyelitis Optica with rituximab: retrospective analysis of 25 patients.
- Does prophylactic postoperative hypervolemic therapy prevent Cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
- Migraine with and without aura and risk for cardiovascular disease.
- The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic.
- Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic.
- Hemi-meningitis: A focal sign heralding a multiSystem necrotizing vasculitis.
- Establishing a diagnosis of benign paroxysmal positional Vertigo through the dix-hallpike and side-lying maneuvers: a critically appraised topic.
- Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients.
- Current evidence and therapeutic strategies for Multiple sclerosis.
- Neuromyelitis Optica and non organ-specific autoimmunity.
- Does cervical manipulative therapy cause vertebral Artery dissection and stroke?
- Neuromyelitis Optica.
- Sniffing out Parkinson Disease: can olfactory testing differentiate parkinsonian disorders?
- The MERITs of evidence-based clinical practice in neurology.
- Caffeine for the prevention and treatment of postdural puncture Headache: debunking the myth.
- Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic.
- Alpha-lipoic acid may improve symptomatic Diabetic polyneuropathy.
- "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative Diseases.
- Treatment of vascular dementia and vascular cognitive impairment.
- Critically appraised topics: the evidence-based neurologist.
- Diagnosis and treatment of neuromyelitis Optica.
- Second-generation antiepileptic drugs' impact on balance: a meta-analysis.
- Neuromyelitis Optica: new findings on pathogenesis.
- Premenstrual Multiple sclerosis pseudoexacerbations: Role of body temperature and prevention with aspirin.
- Neuromyelitis optica Brain lesions localized at sites of high aquaporin 4 expression.
- Not every patient with Multiple sclerosis should be treated at time of diagnosis.
- Neuromyelitis Optica IgG predicts relapse after longitudinally extensive transverse myelitis.
- Brain abnormalities in neuromyelitis optica.
- Acute disseminated encephalomyelitis: distinction from Multiple sclerosis and treatment issues.
- Acute transverse myelitis: is the "idiopathic" form vanishing?
- Seizure prophylaxis in patients with Brain tumors: a meta-analysis.
- Neuromyelitis Optica: current concepts.
- Practical consultations: Multiple sclerosis.
- Postinfectious encephalomyelitis.
- Neuromyelitis Optica: clinical predictors of a relapsing course and survival.
- Randomized controlled trials to assess therapies for Multiple sclerosis.
- Neuromyelitis Optica (Devic's syndrome).
- Early versus late antiepileptic drug withdrawal for people with Epilepsy in remission.
- A randomized trial of intravenous immunoglobulin in Inflammatory demyelinating optic neuritis.
- Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures.
- Multiple sclerosis: current pathophysiological concepts.
- Extratrigeminal short-lasting unilateral neuralgiform Headache with conjunctival injection and tearing (SUNCT): new pathophysiologic entity or variation on a theme?
- The natural history of Multiple sclerosis: a geographically based study: 8: familial Multiple sclerosis.
- The natural history of Multiple sclerosis: implications for trial design.
- The clinical course of neuromyelitis Optica (Devic's syndrome).
- Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS.
- Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonography.
- Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affecting the initiation and safety of anticoagulation.
- Denaturation fingerprinting: two related mutation detection methods especially advantageous for high G + C regions.
- Clinical outcome measures and rating scales in Multiple sclerosis trials.
- Multifocal Brain MRI artifacts secondary to embolic metal fragments.
- A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in Multiple sclerosis.
- Genetic variation in the tumor necrosis factor alpha gene and the outcome of Multiple sclerosis.
- The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions.
- Is there a neurologist on this flight?
- A role for humoral mechanisms in the pathogenesis of Devic''s neuromyelitis Optica.
- Management of chronic central neuropathic pain following traumatic Spinal cord injury.
Schools
University Saskatchewan
Mayo Clinic
University Western Ontario
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Ataxia
- Bell's Palsy
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Super Doctor
Education
-
Mayo School of Graduate Medical Education -
University of Saskatchewan College of Medicine
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1194708586 | |
| NPPES Provider LastName | WINGERCHUK | |
| NPPES Provider FirstName | DEAN | |
| NPPES Provider ZIPCode | 852595404 | |
| NPPES Provider State | AZ | |
| Specialty Description | Neurology | |
| Total Claim Count | 234.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194708586 |
| Last Name Of The Provider | WINGERCHUK |
| First Name Of The Provider | DEAN |
| View All |
Similar Doctors
|
|
Dr. Jeffrey D. Steier, MD |
|
|
Dr. Richard J. Caselli, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard W. Goodell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie Grill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniela Caltaru, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marisa S. Sosinsky, MD |
|
|
Dr. Gretchen E. Schlosser Covell, MD |
|
|
Dr. Dan J. Capampangan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Constantine G. Moschonas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kate W. Grimsrud, MD |
|
|
Dr. Louis F. Romain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd J. Schwedt, MD
This Doctor is OpenDoctor Recommended.
|